Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC. | exhibit322q22021.htm |
| EX-99.1 - CERTAIN LITIGATION MATTERS - ALTRIA GROUP, INC. | exhibit991q22021.htm |
| EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC. | exhibit321q22021.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC. | exhibit312q22021.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC. | exhibit311q22021.htm |
| 10-Q - 10-Q - ALTRIA GROUP, INC. | mo-20210630.htm |
Exhibit 99.2
TRIAL SCHEDULE FOR CERTAIN CASES
Below is a schedule, as of July 26, 2021, setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for but not in trial through September 30, 2021.
2021
Engle progeny
| July | 0 | ||||
| August | 1 | ||||
| September | 4 | ||||
As of July 26, 2021, there are no Engle progeny cases in trial.
Other Individual Smoking & Health
| July | 0 | ||||
| August | 0 | ||||
| September | 0 | ||||
As of July 26, 2021, there are no non-Engle progeny cases in trial.